or Try an Advanced Search...

    Technical Analysis for NBSE - NeuBase Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.38 -3.20% -0.01
    NBSE closed down 3.2 percent on Friday, May 10, 2024, on 64 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NBSE trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Earnings Movers Other 0.00%
    BB Squeeze + Lower Band Touch Range Contraction 0.00%
    Below Lower BB Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    New 52 Week Closing Low Bearish -3.20%
    Bollinger Band Squeeze Range Contraction -3.20%
    Earnings Movers Other -3.20%
    BB Squeeze + Lower Band Touch Range Contraction -3.20%
    Older End-of-Day Signals for NBSE ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown 6 days ago
    Down 3% 6 days ago
    Fell Below Previous Day's Low 6 days ago
    Rose Above Lower Bollinger Band 6 days ago
    Down 2 % 6 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    NBSE Chart by TradingView
    Basic chart:

    Profile

    NeuBase Therapeutics, Inc., a biotechnology company, engages in the development of various antisense therapies to address genetic diseases in the United States. The company offers gene silencing therapies, including the proprietary PATrOL platform, a peptide-nucleic acid antisense oligonucleotide for genetic diseases caused by mutant proteins, including the Huntington's disease and myotonic dystrophy, as well as various other genetic disorders. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biology Acid Dystrophy Gene Expression Genetic Diseases Huntington's Disease Oligonucleotide DNA RNA Myotonic Dystrophy Nucleic Acids Genetic Disorder Gene Silencing

    Is NBSE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 5 NeuBase Therapeutics announces receipt of Nasdaq notice
    Apr 5 NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
    Nov 27 Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
    See more NBSE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.7
    52 Week Low 0.36
    Average Volume 149,027
    200-Day Moving Average 0.76
    50-Day Moving Average 0.60
    20-Day Moving Average 0.42
    10-Day Moving Average 0.41
    Average True Range 0.04
    RSI (14) 31.03
    ADX 23.0
    +DI 15.61
    -DI 28.12
    Chandelier Exit (Long, 3 ATRs) 0.35
    Chandelier Exit (Short, 3 ATRs) 0.48
    Upper Bollinger Bands 0.45
    Lower Bollinger Band 0.38
    Percent B (%b) -0.11
    BandWidth 14.60
    MACD Line -0.04
    MACD Signal Line -0.05
    MACD Histogram 0.0089
    Fundamentals Value
    Market Cap 1.41 Million
    Num Shares 3.73 Million
    EPS -18.60
    Price-to-Earnings (P/E) Ratio -0.02
    Price-to-Sales 0.00
    Price-to-Book 0.28
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.42
    Resistance 3 (R3) 0.42 0.40 0.41
    Resistance 2 (R2) 0.40 0.39 0.40 0.41
    Resistance 1 (R1) 0.39 0.39 0.38 0.39 0.41
    Pivot Point 0.38 0.38 0.37 0.38 0.38
    Support 1 (S1) 0.36 0.37 0.36 0.36 0.35
    Support 2 (S2) 0.35 0.36 0.35 0.35
    Support 3 (S3) 0.34 0.35 0.35
    Support 4 (S4) 0.34